Mieres, N.G.; Simião, S.d.O.; Cruz, L.S.; Melo, R.C.d.; Khalil, N.M.; Bonini, J.S.; Rego, F.G.d.M.; Sari, M.H.M.; Pontarolo, R.; Lazo, R.E.L.;
et al. Bioadhesive Eudragit RL®100 Nanocapsules for Melanoma Therapy: A Repurposing Strategy for Propranolol. Pharmaceutics 2025, 17, 718.
https://doi.org/10.3390/pharmaceutics17060718
AMA Style
Mieres NG, Simião SdO, Cruz LS, Melo RCd, Khalil NM, Bonini JS, Rego FGdM, Sari MHM, Pontarolo R, Lazo REL,
et al. Bioadhesive Eudragit RL®100 Nanocapsules for Melanoma Therapy: A Repurposing Strategy for Propranolol. Pharmaceutics. 2025; 17(6):718.
https://doi.org/10.3390/pharmaceutics17060718
Chicago/Turabian Style
Mieres, Naomi Gerzvolf, Soraia de Oliveira Simião, Luiza Stolz Cruz, Rafaela Cirillo de Melo, Najeh Maissar Khalil, Juliana Sartori Bonini, Fabiane Gomes de Moraes Rego, Marcel Henrique Marcondes Sari, Roberto Pontarolo, Raul Edison Luna Lazo,
and et al. 2025. "Bioadhesive Eudragit RL®100 Nanocapsules for Melanoma Therapy: A Repurposing Strategy for Propranolol" Pharmaceutics 17, no. 6: 718.
https://doi.org/10.3390/pharmaceutics17060718
APA Style
Mieres, N. G., Simião, S. d. O., Cruz, L. S., Melo, R. C. d., Khalil, N. M., Bonini, J. S., Rego, F. G. d. M., Sari, M. H. M., Pontarolo, R., Lazo, R. E. L., Reolon, J. B., & Ferreira, L. M.
(2025). Bioadhesive Eudragit RL®100 Nanocapsules for Melanoma Therapy: A Repurposing Strategy for Propranolol. Pharmaceutics, 17(6), 718.
https://doi.org/10.3390/pharmaceutics17060718
